Literature DB >> 21985034

NBD-labeled phospholipid accelerates apolipoprotein C-II amyloid fibril formation but is not incorporated into mature fibrils.

Timothy M Ryan1, Michael D W Griffin, Michael F Bailey, Peter Schuck, Geoffrey J Howlett.   

Abstract

Human apolipoprotein (apo) C-II is one of several lipid-binding proteins that self-assemble into fibrils and accumulate in disease-related amyloid deposits. A general characteristic of these amyloid deposits is the presence of lipids, known to modulate individual steps in amyloid fibril formation. ApoC-II fibril formation is activated by submicellar phospholipids but inhibited by micellar lipids. We examined the mechanism for the activation by submicellar lipids using the fluorescently labeled, short-chain phospholipid 1-dodecyl-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]-2-hydroxyglycero-3-phosphocholine (NBD-lyso-12-PC). Addition of submicellar NBD-lyso-12-PC increased the rate of fibril formation by apoC-II approximately 2-fold. Stopped flow kinetic analysis using fluorescence detection and low, non-fibril-forming concentrations of apoC-II indicated NBD-lyso-12-PC binds rapidly, on the millisecond time scale, followed by the slower formation of discrete apoC-II tetramers. Sedimentation velocity analysis showed NBD-lyso-12-PC binds to both apoC-II monomers and tetramers at approximately five sites per monomer with an average dissociation constant of approximately 10 μM. Mature apoC-II fibrils formed in the presence of NBD-lyso-12-PC were devoid of lipid, indicating a purely catalytic role for submicellar lipids in the activation of apoC-II fibril formation. These studies demonstrate the catalytic potential of small amphiphilic molecules in controlling protein folding and fibril assembly pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21985034      PMCID: PMC4157729          DOI: 10.1021/bi201192r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  46 in total

1.  Raft lipids as common components of human extracellular amyloid fibrils.

Authors:  Gerald P Gellermann; Thomas R Appel; Astrid Tannert; Anja Radestock; Peter Hortschansky; Volker Schroeckh; Christian Leisner; Tim Lütkepohl; Shmuel Shtrasburg; Christoph Röcken; Mordechai Pras; Reinhold P Linke; Stephan Diekmann; Marcus Fändrich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

2.  Phospholipid catalysis of diabetic amyloid assembly.

Authors:  Jefferson D Knight; Andrew D Miranker
Journal:  J Mol Biol       Date:  2004-08-27       Impact factor: 5.469

3.  Low concentrations of sodium dodecyl sulfate induce the extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH.

Authors:  Suguru Yamamoto; Kazuhiro Hasegawa; Itaru Yamaguchi; Shinobu Tsutsumi; József Kardos; Yuji Goto; Fumitake Gejyo; Hironobu Naiki
Journal:  Biochemistry       Date:  2004-08-31       Impact factor: 3.162

4.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.

Authors:  H Shao; S Jao; K Ma; M G Zagorski
Journal:  J Mol Biol       Date:  1999-01-15       Impact factor: 5.469

5.  The structure and interactions of human apolipoprotein C-II in dodecyl phosphocholine.

Authors:  Christopher A MacRaild; Geoffrey J Howlett; Paul R Gooley
Journal:  Biochemistry       Date:  2004-06-29       Impact factor: 3.162

6.  Formation of amyloid fibers triggered by phosphatidylserine-containing membranes.

Authors:  Hongxia Zhao; Esa K J Tuominen; Paavo K J Kinnunen
Journal:  Biochemistry       Date:  2004-08-17       Impact factor: 3.162

7.  Fibrillar amyloid protein present in atheroma activates CD36 signal transduction.

Authors:  Lea A Medeiros; Tayeba Khan; Joseph B El Khoury; Chi L L Pham; Danny M Hatters; Geoffrey J Howlett; Roland Lopez; Kevin D O'Brien; Kathryn J Moore
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

8.  Multiple effects of trehalose on protein folding in vitro and in vivo.

Authors:  M A Singer; S Lindquist
Journal:  Mol Cell       Date:  1998-04       Impact factor: 17.970

9.  Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques.

Authors:  P Westermark; G Mucchiano; T Marthin; K H Johnson; K Sletten
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

10.  The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide.

Authors:  L Obici; V Bellotti; P Mangione; M Stoppini; E Arbustini; L Verga; I Zorzoli; E Anesi; G Zanotti; C Campana; M Viganò; G Merlini
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

View more
  4 in total

1.  Apolipoprotein C-II Adopts Distinct Structures in Complex with Micellar and Submicellar Forms of the Amyloid-Inhibiting Lipid-Mimetic Dodecylphosphocholine.

Authors:  Timothy M Ryan; Michael D W Griffin; Duncan J McGillivray; Robert B Knott; Kathleen Wood; Colin L Masters; Nigel Kirby; Cyril C Curtain
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

2.  Analysis of high-affinity assembly for AMPA receptor amino-terminal domains.

Authors:  Huaying Zhao; Anthony J Berger; Patrick H Brown; Janesh Kumar; Andrea Balbo; Carrie A May; Ernesto Casillas; Thomas M Laue; George H Patterson; Mark L Mayer; Peter Schuck
Journal:  J Gen Physiol       Date:  2012-04-16       Impact factor: 4.086

3.  Accounting for photophysical processes and specific signal intensity changes in fluorescence-detected sedimentation velocity.

Authors:  Huaying Zhao; Jia Ma; Maria Ingaramo; Eric Andrade; Jeff MacDonald; Glen Ramsay; Grzegorz Piszczek; George H Patterson; Peter Schuck
Journal:  Anal Chem       Date:  2014-08-28       Impact factor: 6.986

4.  Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis.

Authors:  Sadichhya Lohani; Emily Schuiteman; Lohit Garg; Dhiraj Yadav; Sami Zarouk
Journal:  Case Rep Nephrol       Date:  2016-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.